The spectrum of quantifiable nicotine metabolite levels detectable in biological samples, such as blood, urine, or saliva, provides a crucial indicator of nicotine exposure. For instance, cotinine, a primary metabolite of nicotine, can be measured to assess recent tobacco use. Different testing methods offer varying levels of sensitivity and detection windows, influencing the scope of measurable values.
Understanding the expected values for these metabolites and the factors that can influence them is vital for accurate interpretation of test outcomes. This knowledge supports diverse applications, including clinical diagnosis, smoking cessation programs, and research studies exploring the effects of nicotine on the body. Historically, assessment of nicotine exposure relied primarily on self-reported data, subject to inaccuracies. Advances in laboratory techniques have enabled objective measurement, providing more reliable insights into individual nicotine intake and its implications for health.
